Stages:

• Early
• Expansion
• Growth
• Middle Market

 

Industries:

Life Sciences & Healthcare

Medical Device

 

Description:

RA Capital Management is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows RA Capital to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization. At RA Capital's core is its TechAtlas research division, a scientifically trained team that maps out competitive landscapes in a continual effort to put data into context, identify breakthroughs, and originate conviction in new ideas. TechAtlas provides RA Capital's investment team and portfolio companies (see Beyond Capital) with strategic intelligence, market research, and other resources. The team's understanding of industry best practices is derived from an extensive collection of case studies documenting the impact of clinical trial design, partnership structures, public market dynamics, and many other factors on valuation and business viability. Additionally, RA Capital offers an Executive-in-Residence (EIR) program for experienced professionals seeking thought partners and a platform from which to survey diverse competitive landscapes in search of worthy projects. The firm might invest a small amount in a very small company, maybe even under $1M in a seed round, or a larger amount in a large company that they think has a lot of upside (they have invested as much as $75M in a single round). But are unlikely to invest a small amount in a large company (e.g. $5M in a $500M to own 1%) unless it's just the first step towards establishing greater ownership.

 

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.